VAKAORA: Physician-Guided Peptide Therapy

Joyful couple sailing together at golden hour, laughing on open water

“Vaka”: the canoe. “Ora”: life. A name inspired by Pacific voyaging and the vitality of life.

Three glass vials on natural linen beside a carved wooden bowl

Single vial on volcanic stone with water droplets

Why Vakaora

A name with roots across Polynesia.

Vaka is the voyaging canoe. Ora is life, health, and vitality. Together they hold a whole idea: the vessel, and the life she carries.

We think about your health the same way. You know where you are headed. Our clinicians, pharmacies, and lot testing exist to keep the canoe seaworthy, so you can spend your energy on the voyage.

Tested lot by lot, published before it ships. Identity confirmed by mass spectrometry, peptide content and endotoxin verified in an ISO/IEC 17025 lab, sterility checked on every batch. If a result is not what it should be, that lot does not ship.

Your journey

Three steps to care

Every protocol begins with a clinician's assessment. If prescribed, your medication is compounded by a licensed pharmacy, with ongoing clinical review.

Stage one · Consultation

Know where you are

Begin with a health intake and a video consultation with a licensed physician. They review your history, labs, and goals to assess whether peptide therapy is appropriate for you.

Clinical guidance, independent of sales
Contraindications screened first
A prescription may not be recommended

Stage two · Prescription

Prescribed for you

If peptide therapy is appropriate, your physician prescribes a specific compound, strength, and duration based on your assessment.

Individual prescriptions, no fixed blends
Only compounds eligible for lawful compounding under Section 503A
Reauthorization at every refill

Stage three · Delivery & ongoing care

Your medication, verified

A licensed U.S. pharmacy compounds your medication under pharmacy board oversight. Each lot is independently tested, and your vial arrives with its certificate. A dedicated care coordinator supports you throughout your care.

Independent ISO 17025 testing, every lot
Your vial's QR code links to its exact COA
Ongoing review with your clinician

The life you're living

Care that makes
room for you.

Sunrise runs. Saturdays with people you love. Work that matters to you. Your clinician considers your daily life alongside your history and labs, shaping your protocol around your needs and reviewing it as they change.

Whole-person careReviews cover sleep, stress, training, and nutrition together

People you knowYour coordinator and prescriber stay reachable between visits

Room to adjustDosing and pauses adjust as your needs change

Ongoing assessmentProtocols end when they no longer fit

Two hikers on a jungle trail approaching a tall tropical waterfall — Trail to the falls · golden light through the canopy

Golden retriever standing at the front of a paddleboard with its owner at golden hour — First seat · golden hour paddle

Woman running on the beach at sunrise — First light run

The protocols

Compounds we work with

We list only compounds a licensed pharmacy can lawfully prepare for an individual patient with a prescription. Each compound's regulatory status is shown.

BPC-157Body Protection Compound

503A rec · Jul 2026

Evaluated by the FDA's compounding advisory committee for ulcerative colitis and recommended for the 503A bulks list. Research centers on gastric protection and soft-tissue repair.

RecoveryGut integrityAthletes: check federation lists

TB-500Thymosin Beta-4 fragment

503A rec · Jul 2026

A peptide studied for its role in cell migration and tissue organization. Recommended for wound healing in July 2026, with final FDA rulemaking pending. Often prescribed alongside BPC-157 as separate compounds your clinician can adjust independently.

Tissue repairWADA prohibited

KPVLysine-Proline-Valine

503A rec · Jul 2026

A natural fragment of α-MSH studied for inflammatory modulation and antimicrobial activity, including oral and topical routes. Recommended in the July 2026 committee vote for inflammatory conditions and wound healing, with final FDA rulemaking pending.

InflammationGut barrier

MOTS-cMitochondrial-derived peptide

503A rec · Jul 2026

Studied for metabolic regulation and exercise-mimetic signaling; evaluated for obesity and bone density. We publish net peptide content on every MOTS-c lot.

MetabolicWADA prohibited

GHK-CuCopper tripeptide

Category 1 · topical

Extensively studied in dermal remodeling and collagen support; moved to the FDA Category 1 list for topical use in May 2026. Injectable GHK-Cu remains under review. We will not offer it unless a lawful compounding pathway is established.

Skin qualityDermal regeneration

TesamorelinGHRH analogue

FDA-approved component

The active ingredient in an FDA-approved prescription medication. Compoundable for individual patients under Section 503A today. Prescribing is strictly individualized; we make no equivalence claims about any branded product.

Body compositionWADA prohibitedScreened contraindications

EpitalonEpithalon

503A rec · Jul 2026

A synthetic tetrapeptide studied for circadian regulation and telomere biology. Recommended with insomnia as the evaluated indication, with final FDA rulemaking pending. Considered only as part of a full sleep and recovery assessment.

Sleep architectureCircadian

SemaxACTH fragment analogue

503A rec · Jul 2026

Studied for neuroprotective and cognitive effects; evaluated for migraine and cerebral ischemia. Prescribed only after a review of your neurological history. Never marketed as a performance enhancer or a substitute for care.

CognitiveNeuroprotective research

Committee recommendations await final FDA rulemaking; we update this list as status changes. We do not offer any compound the FDA has designated as raising significant safety concerns, fixed-dose blends, or anything outside a lawful compounding pathway.

Three premium vials styled on linen with carved bowl and tropical leaf

“A vial can test 99% pure and still contain half the labeled dose. We test quantity as well as purity and publish both results.”The Vakaora Standard

The Vakaora Standard

Purity is one part of the picture.

Purity

HPLC separates the target peptide from impurities such as truncated sequences and oxidation products to assess purity.

≥ 98.0% acceptance · target 99%+

Identity

Mass spectrometry checks the peptide's measured molecular mass against its expected mass to help verify identity.

± 0.5 Da of theoretical MW

Quantity

Net peptide content measures peptide mass after accounting for salt and moisture. We publish the result and check the quantity against the label claim.

≥ 80% NPC · label claim verified

Endotoxin & sterility

LAL testing detects bacterial endotoxins, which can trigger an inflammatory response. Sterility culture checks for viable microorganisms under the test conditions.

< 1.0 EU/mg (our median < 0.05) · USP <71> pass

Heavy metals

ICP-MS screens every lot for lead, arsenic, cadmium, and mercury, because synthesis routes and glassware can leave traces that purity testing never sees.

Screened against USP <232> limits

Lot verification

Your vial's results, ready to review.

Each vial's QR code and lot number link to a full certificate from a named ISO/IEC 17025 laboratory, with results for purity, identity, net peptide content, endotoxin, and sterility. Try the demo below. The live library will include every lot produced for Vakaora.

Open books, named lab. Every certificate names the ISO/IEC 17025 laboratory that ran it, with full methods and results. Your clinician can review any lot's data with you before a single vial is dispensed.

Verify a lot

Enter a lot number from any vial label

Demo lots: VA-2609-BPC · VA-2611-TB5 · VA-2614-GHK

Lot VA-2609-BPC

BPC-157

Verified

Begin

Start with a conversation.

Tell us about your health and what you'd like to change. A licensed clinician reviews your information and assesses whether a peptide protocol may be appropriate for you.

Your first steps

Three steps, approximately 48 hours in total; timing may vary

01Health intake: 10 minutes, online
02Video consultation with a licensed physician
03If prescribed: compounded, tested, and shipped with its COA

Book your consultation

Consultation fee applied to your first protocol · Currently licensed in 12 states. We'll let you know right away if care isn't available in your state yet.

For the voyage ahead.

BPC-157 · 10 mg

A name with roots across Polynesia.